ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019
The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.
Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Achieving universal genetic assessment for women with ovarian cancer: Are we there yet? A systematic review and meta-analysis.Gynecologic oncology · 2021Pooled it
- Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now.JCO oncology practice · 2025Article
- Germline BRCA testing in Denmark following invasive breast cancer: Progress since 2000.Acta oncologica (Stockholm, Sweden) · 2025Observational
- Gynecologic Care of Black Breast Cancer Survivors.Current breast cancer reports · 2024Article
- Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients.Annals of surgical oncology · 2023Article
- Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer.JAMA network open · 2022Article
- Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.JAMA network open · 2022Article
- Evaluation of Germline Genetic Testing Criteria in a Hospital-Based Series of Women With Breast Cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020Article
Corrections and comments
- Commented on by
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.